文献速递重症综合管理与镇静镇痛

快速序贯器官衰竭评估评分在不同收入地区ICU脓毒症患者中的预后评估

Prognostic evaluation of quick sequential organ failure assessment score in ICU patients with sepsis across different income settings.
PubMed 文献 · Crit Care · 2024-01-23
一句话结论在因脓毒症入住ICU的患者中,qSOFA与28天死亡率独立相关(校正RR 1.09,95%CI 1.00-1.18,P=0.038);高收入地区仅与3天早期死亡率相关。

本研究为MOSAICS II研究(亚洲ICU脓毒症流行病学国际前瞻性观察研究)的二次分析,纳入343个ICU、22个国家的4826例脓毒症患者,按低/中低收入(LLMIC)、中高收入(UMIC)和高收入(HIC)国家/地区分层,评估入ICU时qSOFA与3天、28天、90天死亡率的关系。结果显示qSOFA升高与28天死亡率增加相关,但仅在LLMIC(P<0.001)和UMIC(P<0.001)中观察到,HIC中无显著关联(P=0.220);90天死亡率同样仅在LLMIC和UMIC中与qSOFA升高相关(P<0.001);而3天死亡率在全部收入地区均随qSOFA升高而增加(P<0.001)。多因素分析校正APACHE II、SOFA、收入地区及3小时内抗生素使用后,qSOFA仍与28天死亡率独立相关(校正RR 1.09,95%CI 1.00-1.18,P=0.038)。

要点

  • 在因脓毒症入住ICU的患者中,校正APACHE II、SOFA、收入地区及3小时内抗生素使用后,qSOFA仍与28天死亡率独立相关(校正RR 1.09,95%CI 1.00-1.18,P=0.038)。
  • qSOFA升高与28天死亡率增加相关,但仅在LLMIC(P<0.001)和UMIC(P<0.001)中观察到,HIC中无显著关联(P=0.220)。
  • qSOFA升高与90天死亡率增加相关,同样仅在LLMIC(P<0.001)和UMIC(P<0.001)中观察到。
  • qSOFA升高与3天死亡率增加相关,在全部收入地区均观察到(P<0.001)。
  • 在LLMIC和UMIC中qSOFA与早期至晚期死亡率相关,而在HIC中仅与早期死亡率相关。

适用人群与场景

  • 因脓毒症入住ICU的患者,来自MOSAICS II研究队列的4826例患者(343个ICU、22个国家/地区),按LLMIC、UMIC和HIC国家/地区分层。

研究设计与关键结果

  • 研究类型:MOSAICS II研究(亚洲ICU脓毒症流行病学国际前瞻性观察研究)的二次分析;样本量:MOSAICS II队列4980例中纳入4826例;中心数:343个ICU、22个国家/地区;人群:因脓毒症入住ICU的患者。
  • qSOFA升高与28天死亡率增加相关,但仅在LLMIC(P<0.001)和UMIC(P<0.001)中观察到,HIC中无显著关联(P=0.220)。
  • qSOFA升高与90天死亡率增加相关,仅在LLMIC(P<0.001)和UMIC(P<0.001)中观察到。
  • qSOFA升高与3天死亡率增加相关,在全部收入地区均观察到(P<0.001)。
  • 多因素分析(改良Poisson回归)校正MOSAICS II研究中识别的混杂因素(包括APACHE II、SOFA、收入国家/地区及3小时内抗生素使用)后,qSOFA仍与28天死亡率相关(校正RR 1.09,95%CI 1.00-1.18,P=0.038)。

证据类型、等级与局限

  • 证据类型:国际前瞻性观察研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在LLMIC和UMIC的ICU中,入ICU时qSOFA升高提示早期至晚期死亡风险增加;在HIC的ICU中,qSOFA升高主要提示早期(3天)死亡风险增加。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is conflicting evidence on association between quick sequential organ failure assessment (qSOFA) and sepsis mortality in ICU patients. The primary aim of this study was to determine the association between qSOFA and 28-day mortality in ICU patients admitted for sepsis. Association of qSOFA with early (3-day), medium (28-day), late (90-day) mortality was assessed in low and lower middle income (LLMIC), upper middle income (UMIC) and high income (HIC) countries/regions.

METHODS: This was a secondary analysis of the MOSAICS II study, an international prospective observational study on sepsis epidemiology in Asian ICUs. Associations between qSOFA at ICU admission and mortality were separately assessed in LLMIC, UMIC and HIC countries/regions. Modified Poisson regression was used to determine the adjusted relative risk (RR) of qSOFA score on mortality at 28 days with adjustments for confounders identified in the MOSAICS II study.

RESULTS: Among the MOSAICS II study cohort of 4980 patients, 4826 patients from 343 ICUs and 22 countries were included in this secondary analysis. Higher qSOFA was associated with increasing 28-day mortality, but this was only observed in LLMIC (p < 0.001) and UMIC (p < 0.001) and not HIC (p = 0.220) countries/regions. Similarly, higher 90-day mortality was associated with increased qSOFA in LLMIC (p < 0.001) and UMIC (p < 0.001) only. In contrast, higher 3-day mortality with increasing qSOFA score was observed across all income countries/regions (p < 0.001). Multivariate analysis showed that qSOFA remained associated with 28-day mortality (adjusted RR 1.09 (1.00-1.18), p = 0.038) even after adjustments for covariates including APACHE II, SOFA, income country/region and administration of antibiotics within 3 h.

CONCLUSIONS: qSOFA was independently associated with 28-day mortality in ICU patients admitted for sepsis. In LLMIC and UMIC countries/regions, qSOFA was associated with early to late mortality but only early mortality in HIC countries/regions.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Li A, Ling L, Qin H, et al. Prognostic evaluation of quick sequential organ failure assessment score in ICU patients with sepsis across different income settings. Crit Care. 2024. PMID: 38263076. doi:10.1186/s13054-024-04804-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。